Login
$TNGX
$24.22 +$0.05 (0.21%) After hours

$TNGX 4 SEC Filings

Filed On Filing
13 Nov 2026 Form 4: Crystal Adam, President, R&D

Received 5,000 shares by exercise or conversion ($14.6K) · Sold 5,000 shares ($125K)

04 Nov 2026 Form 4: Crystal Adam, President, R&D

Received 5,000 shares by exercise or conversion ($14.6K) · Sold 5,000 shares ($112K)

04 Nov 2026 Form 4: Newcomb Jessica, Principal Accounting Officer

Sold 7,031 shares ($158K)

05 Oct 2026 Form 4: Crystal Adam, President, R&D

Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($661K)

24 Sep 2026 Form 4: Newcomb Jessica, Principal Accounting Officer

Sold 8,200 shares ($199K)

03 Sep 2026 Form 4: Crystal Adam, President, R&D

Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($604K)

05 Aug 2026 Form 4: Crystal Adam, President, R&D

Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($736K)

02 Jul 2026 Form 4: Crystal Adam, President, R&D

Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($799K)

23 Jun 2026 Form 4: Azelby Robert, Director

Received 5,740 shares as a grant or award · Granted 35,910 Stock Option (Right to Buy)

08 Jun 2026 Form 4: Ketchum John B, Director

Received 4,000 shares as a grant or award · Granted 25,000 Stock Option (Right to Buy)

08 Jun 2026 Form 4: Calhoun Lesley Ann, Director

Received 4,000 shares as a grant or award · Granted 25,000 Stock Option (Right to Buy)

08 Jun 2026 Form 4: Rothenberg Mace, Director

Received 4,000 shares as a grant or award · Granted 25,000 Stock Option (Right to Buy)

08 Jun 2026 Form 4: Lee Sung, Director

Received 570 shares as a grant or award · Granted 3,570 Stock Option (Right to Buy)

03 Jun 2026 Form 4: Crystal Adam, President, R&D

Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($618K)

05 May 2026 Form 4: Crystal Adam, President, R&D

Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($573K)

05 May 2026 Form 4: Gall Matthew, Chief Financial Officer

Received 40,000 shares as a grant or award · Granted 240,000 Stock Option (Right to Buy)

01 May 2026 Form 4: Lee Sung, Director

Received 12,300 shares as a grant or award · Granted 5,200 Stock Option (Right to Buy)

16 Apr 2026 Form 4: Crystal Adam, President, R&D

Received 38,460 shares by exercise or conversion ($200K) · Sold 38,460 shares ($962K)

02 Apr 2026 Form 4: Crystal Adam, President, R&D

Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($572K)

27 Mar 2026 Form 4: Crystal Adam, President, R&D

Received 12,000 shares by exercise or conversion ($62.4K) · Sold 12,000 shares ($241K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support